Pliant Therapeutics is a clinical stage biotechnology company unraveling and targeting the key biological pathways driving fibrosis. By leveraging our powerful product discovery engine, Pliant is developing novel therapeutics that seek to halt progression of fibrotic diseases — ultimately, preserving organ function.
